Replies to post #32816 on Regen BioPharma Inc (RGBP)

[#1_USA_DEPLORABLE]

David Koos has no use
being in the OTC
yet he professes
to have "successes"
and has failed UTTERLY
so when you invest
in any "grotesque"
get ready to digest
the problem lies before ones eyes
and ones account suffers DRAMATICALLY!
RGBP.

[Dogfish44]

Evaluating RGBP doesn't require any poetry, just common sense. RGBP; as well as the preceding leaderless ships has been at this since 2001 and NOT a SINGLE PRODUCT has made it to market, successfully completed Phase 3, or even Phase 1.

RGBP was even granted the go ahead for Phase 1 with HemaX and could NOT even begin that process. The sole stated purpose of the spin off to RGBP was HemaX.

If you want to understand the direction of RGBP, DD on these companies run by Konman Koos makes it clear.

Career History
Chairman/Pres/CEO/Interim CFO Entest Group Inc, 2/2018-PRESENT
Chairman/CEO/Secy/Treasurer Zander Therapeutics Inc, 2/2017-PRESENT
Chairman/CEO Regen Biopharma Inc, 4/2015-PRESENT
Chairman/Pres/CEO/Acting CFO/SecyBio-Matrix Scientific Group Inc, 6/2006-PRESENT
Chairman/Pres/CEO/Interim CFOEntest Biomedical Inc, 8/2011-2/2018
Chairman/Pres/CEO/Interim CFO/SecyZander Therapeutics Inc, UNKNOWN-2/2017
Chairman/Pres/CEO/Treasurer/SecyRegen Biopharma Inc, 2/2015-4/2015
Chairman/Pres/CEO/Interim CFO/Treasurer/SecyRegen Biopharma Inc, 5/2013-2/2015
Chairman/CEO/Interim CFO/Treasurer/SecyRegen Biopharma Inc, 4/2012-5/2013
Chairman/President/CEO/SecyEntest Biomedical Inc, 3/2010-8/2011
Chairman/Pres/CEO/CFO/SecyEntest Biomedical Inc, 7/2009-3/2010
President/Managing DirectorCell Source Research Inc, 12/2001-UNKNOWN